HIGHBRIDGE CAPITAL MANAGEMENT LLC - BENITEC BIOPHARMA LTD ownership

Back to all holdings Add to watchlist

BENITEC BIOPHARMA LTD's ticker is BNTC and the CUSIP is 082053307. A total of 8 filers reported holding BENITEC BIOPHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of BENITEC BIOPHARMA LTD
ValueSharesWeighting
Q1 2019$527,000
+28.5%
269,066
-1.4%
0.02%
+33.3%
Q4 2018$410,000
-36.6%
273,0100.0%0.01%
-20.0%
Q3 2018$647,000
-57.8%
273,010
-64.6%
0.02%
-51.6%
Q2 2018$1,534,000–770,780–0.03%–
 Download
Other shareholders
BENITEC BIOPHARMA LTD shareholders Q4 2018
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 7,217$13,0000.01%
WEDBUSH SECURITIES INC 26,950$50,0000.01%
DEUTSCHE BANK AG\ 1,000$1,0000.00%
ACADIAN ASSET MANAGEMENT LLC 4,159$8,0000.00%
UBS Group AG 1,458$2,0000.00%
View complete list of BENITEC BIOPHARMA LTD shareholders